header logo image

Bio-Thera Solutions and Biogen Publish Phase 3 Clinical Trial Data for TOFIDENCE (BAT1806/BIIB800), an approved Biosimilar referencing tocilizumab in…

September 13th, 2024 2:39 am

Bio-Thera Solutions and Biogen Publish Phase 3 Clinical Trial Data for TOFIDENCE (BAT1806/BIIB800), an approved Biosimilar referencing tocilizumab in Arthritis Research & Therapy  PR Newswire

See more here:
Bio-Thera Solutions and Biogen Publish Phase 3 Clinical Trial Data for TOFIDENCE (BAT1806/BIIB800), an approved Biosimilar referencing tocilizumab in...

Related Post

Tags:

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick